ROBERT MCLEOD: Open Payments
NPI 1275553893 · MENDOTA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,221 in 22 payments from 7 companies in 2025. Trend: 2023 $202 · 2024 $933 · 2025 $1,221
Food & beverage: $1,221
| Company | Payments | Amount |
|---|---|---|
| Madrigal Pharmaceuticals | 9 | $437 |
| Novo Nordisk Inc | 6 | $166 |
| Phathom Pharmaceuticals, Inc. | 3 | $146 |
| ABBVIE INC. | 1 | $125 |
| Ardelyx, Inc. | 1 | $123 |
| Eisai Inc. | 1 | $122 |
| ABIOMED | 1 | $101 |
Products named: REZDIFFRA, VOQUEZNA, VRAYLAR, Ozempic, IBSRELA, Leqembi, Wegovy.
Industry payments across CA — which companies pay providers there.
